Table 1.
Clinical, biological and immunological characteristic at admission of the 12 patients with AS-AIH
| Patients | Clinical and biological parameters | Immunological | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age (year)/gender(M/F) | ALT (IU/L) | ALP (IU/L) | TBIL (μmol/L) | INR | MELD score | IgG (g/L) | ANA | ASMA | Anti-LKM-1 | |
| 1 | 50/F | 205 | 124 | 252.8 | 1.58 | 25 | 18.5 | 1:320 | n | n |
| 2 | 45/F | 267 | 73 | 337.4 | 1.88 | 25 | 49.2 | 1:320 | p | n |
| 3 | 68/M | 165 | 159 | 242 | 1.63 | 22 | 31.9 | n | n | n |
| 4 | 53/F | 279 | 237 | 268.7 | 1.53 | 22 | 12.2 | n | p | n |
| 5 | 55/F | 408 | 336 | 321.8 | 1.57 | 23 | 44.9 | 1:160 | n | n |
| 6 | 58/F | 311 | 130 | 175.4 | 1.89 | 22 | 28.5 | n | n | n |
| 7 | 54/F | 228 | 211 | 216.1 | 1.92 | 23 | 23.4 | 1:320 | p | n |
| 8 | 43/F | 1223 | 197 | 329.6 | 1.86 | 27 | 35.6 | 1:320 | n | n |
| 9 | 55/F | 498 | 216 | 250.3 | 1.57 | 22 | 28.2 | 1:5120 | n | n |
| 10 | 36/F | 276 | 153 | 378.5 | 1.68 | 24 | 16.1 | 1:3200 | n | n |
| 11 | 54/F | 214 | 245 | 461 | 1.75 | 25 | 11.4 | 1:320 | n | n |
| 12 | 65/F | 313 | 101 | 533.1 | 1.89 | 27 | 28.5 | 1:100 | n | n |
ALT, alanine aminotransferase; ALP, alkaline phosphatase; TBIL, total bilirubin; INR, international normalized ratio; MELD, the model for end stage liver disease scores; IgG, immunoglobulin G; ANA, antinuclear antibodies; ASMA, anti-smooth muscle antibodies; anti-LKM-1, anti-liver kidney microsomal-1 antibody
p, positive; n, negative